Medline Anterior Hip Kit Recall Issued for Quality Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 60 kits containing Bupivacaine Hydrochloride due to quality issues from the manufacturer.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 12, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP is issuing a recall for specific Medline kits containing B. Braun convenience kits that include Bupivacaine Hydrochloride in Dextrose Injection, USP. The action stems from a voluntary recall by Huons Co, Ltd. due to quality issues.
Which Products Are Affected
MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G. Quantity: 60 kits. UDI/DI 10198459280559 (each), 40198459280550 (case), Lot Number 25DBF430. Distributed in OH, CA, IL, IN, FL, SC, AZ, NJ. Recall number Z-2747-2026. Classification: Class I.
What You Should Do
The recalling firm initiated the voluntary recall. Contact Medline Industries, LP for additional information.
Why This Matters
This is a Class I recall involving a product that may pose serious health risks.
Source
FDA recall Z-2747-2026, report date 20260729.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (838 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 12, 2026.
Frequently Asked Questions
Common questions about this FDA recall.